These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2138478)

  • 1. Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells.
    Ching LM; Finlay GJ; Joseph WR; Baguley BC
    Eur J Cancer; 1990 Jan; 26(1):49-54. PubMed ID: 2138478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
    Baguley BC; Wilson WR
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.
    Schneider E; Darkin SJ; Lawson PA; Ching LM; Ralph RK; Baguley BC
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1783-90. PubMed ID: 2850193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cells.
    Baguley BC; Finlay GJ
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):205-10. PubMed ID: 3356208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.
    Baguley BC; Grimwade CD; Kernohan AR
    Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1337-41. PubMed ID: 3841068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antitumor agents. 52. Carbamate analogues of amsacrine with in vivo activity against multidrug-resistant P388 leukemia.
    Rewcastle GW; Baguley BC; Atwell GJ; Denny WA
    J Med Chem; 1987 Sep; 30(9):1576-81. PubMed ID: 3625706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
    Finlay GJ; Baguley BC
    Eur J Cancer; 1990; 26(5):586-9. PubMed ID: 1698074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):271-7. PubMed ID: 2702982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.
    Finlay GJ; Holdaway KM; Baguley BC
    Cancer Chemother Pharmacol; 1994; 34(2):159-65. PubMed ID: 8194167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
    Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
    Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.
    Baguley BC; Finlay GJ
    J Natl Cancer Inst; 1988 Apr; 80(3):195-9. PubMed ID: 3346911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice.
    Baguley BC; Kernohan AR; Wilson WR
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1607-13. PubMed ID: 6688994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential growth inhibition of cultured mammalian cells: comparison of clinical antitumour agents and amsacrine derivatives.
    Wilson WR; Tapp SM; Baguley BC
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):383-9. PubMed ID: 6546720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma.
    Rewcastle GW; Denny WA; Wilson WR; Baguley BC
    Anticancer Drug Des; 1986 Nov; 1(3):215-22. PubMed ID: 3450294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
    Fiebig HH; Schmid JR; Bieser W; Henss H; Lohr GW
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):937-48. PubMed ID: 3665999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance.
    Baguley BC; Holdaway KM; Fray LM
    J Natl Cancer Inst; 1990 Mar; 82(5):398-402. PubMed ID: 2154584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
    Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
    J Med Chem; 1987 Apr; 30(4):652-8. PubMed ID: 3560159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.
    Fiebig HH; Berger DP; Köpping K; Ottenheijm HC; Zylicz Z
    J Cancer Res Clin Oncol; 1990; 116(6):550-6. PubMed ID: 2254373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.